REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro Oftalmologico Dr. Wilson Fuentes Galvis Ips Sas Zomac (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Centro Oftalmologico Dr. Wilson Fuentes Galvis Ips Sas Zomac Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Centro Oftalmologico Dr. Wilson Fuentes Galvis Ips Sas Zomac is based in Colombia, with the head office in Arauca. It operates in the Ambulatory Health Care Services industry. The company was established on February 20, 2020. From the latest financial highlights, Centro Oftalmologico Dr. Wilson Fuentes Galvis Ips Sas Zomac reported a net sales revenue increase of 17.58% in 2022. Its’ total assets recorded a growth of 1.27%. In, 2022, the company’s net profit margin decreased by 2.69%.

Headquarters
Cra 15 No. 13A - 18
Arauca; Arauca;

Contact Details: Purchase the Centro Oftalmologico Dr. Wilson Fuentes Galvis Ips Sas Zomac report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centro Oftalmologico Dr. Wilson Fuentes Galvis Ips Sas Zomac report to view the information.
Incorporation Date:
February 20, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro Oftalmologico Dr. Wilson Fuentes Galvis Ips Sas Zomac report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
17.58%
Total operating revenue
17.58%
Operating profit (EBIT)
20.92%
Net Profit (Loss) for the Period
-25.06%
Total assets
1.27%
Total equity
1.9%
Operating Profit Margin (ROS)
0.74%
Net Profit Margin
-2.69%
Return on Equity (ROE)
-1.14%
Quick Ratio
0.24%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?